Tag archive for ‘Michel Revel’
Jewish Business News On Monday, October 6th, 2014

Kadimastem Approached the FDA Regarding Its ALS Treatment

– The company recently reported positive results in its first pre-clinical trial for the treatment of ALS. – Israeli biotechnology company Kadimastem announces today that it approached the FDA regarding More...

Jewish Business News On Sunday, August 3rd, 2014

Kadimastem to collaborate with Merck Serono

–   Israeli biotechnology company Kadimastem (TASE: KDST) has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis More...

Wordpress site Developed by Fixing WordPress Problems